Perfil
Andrew M.
Sadosky worked as a Director at Primus Therapeutics, Inc. from 2010 to 2011.
He holds an MBA from the University of Pennsylvania and an undergraduate degree from Rutgers State University of New Jersey.
Antiguos cargos conocidos de Andrew M. Sadosky.
Empresas | Cargo | Fin |
---|---|---|
Primus Therapeutics, Inc.
Primus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Primus Therapeutics, Inc. is a development stage company. It intends to license, develop, market and sell consumer self-care products for preventing and ameliorating the symptoms of common ailments such as cough, cold, influenza, joint pain, gingivitis, products promoting cardiovascular health and analgesics for muscle pain/inflammation. It intends to sell its products under the trademarks PreVenza and Duract. The company was founded by Dennis M. O'Donnell on August 17, 2010 and is headquartered in Skillman, NJ. | Director/Miembro de la Junta | 01/01/2011 |
Formación de Andrew M. Sadosky.
University of Pennsylvania | Masters Business Admin |
Rutgers State University of New Jersey | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Primus Therapeutics, Inc.
Primus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Primus Therapeutics, Inc. is a development stage company. It intends to license, develop, market and sell consumer self-care products for preventing and ameliorating the symptoms of common ailments such as cough, cold, influenza, joint pain, gingivitis, products promoting cardiovascular health and analgesics for muscle pain/inflammation. It intends to sell its products under the trademarks PreVenza and Duract. The company was founded by Dennis M. O'Donnell on August 17, 2010 and is headquartered in Skillman, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew M. Sadosky